Claude Preudhomme
0000-0002-1267-9546
12 papers found
Refreshing results…
Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41
LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA study
Prognostic impact ofDDX41germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study
Early detection of WT1 measurable residual disease identifies high-risk patients, independent of transplantation in AML
Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapy
Transcriptomic and genomic heterogeneity in blastic plasmacytoid dendritic cell neoplasms: from ontogeny to oncogenesis
Prognostic significance of concurrent gene mutations in intensively treated patients with IDH-mutated AML, an ALFA study
Horizontal meta-analysis identifies common deregulated genes across AML subgroups providing a robust prognostic signature
Effects of azacitidine in 93 patients with IDH1/2 mutated acute myeloid leukemia/myelodysplastic syndromes: a French retrospective multicenter study
A Personalized Approach to Guide Allogeneic Stem Cell Transplantation in Younger Adults with Acute Myeloid Leukemia.
Inherited transmission of the CSF3R T618I mutational hotspot in familial chronic neutrophilic leukemia
How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?
Missing publications? Search for publications with a matching author name.